| Literature DB >> 35684317 |
Natalia Pachura1, Robert Kupczyński2, Kamila Lewandowska2, Maciej Włodarczyk3, Marta Klemens1, Piotr Kuropka4, Renata Nowaczyk4, Małgorzata Krzystek-Korpacka5, Iwona Bednarz-Misa5, Tomasz Sozański5, Krystyna Pogoda-Sewerniak2, Antoni Szumny1.
Abstract
Ilex paraguariensis, the holly tree, is a plant with recognized biological properties, whose aqueous infusions are known as "Yerba mate", that regulate lipid metabolism, reduce obesity, and improve brain stimulation. In the present study, the effect of standardized saponin and terpenoid fractions of a European taxon, Ilex aquifolium, on blood biochemical parameters in a rat model of metabolic disorder, (fa/fa) Zucker, are presented. The profiles of the volatile fractions of two species and six European varieties of Ilex were investigated. After selecting the best variety, the saponin and terpenoid fractions were isolated and standardized, and animals were fed 10 mg kg-1 b.w. for 8 weeks. A statistically significant decrease in liver adiposity was observed, confirmed by histology and quantitative identification (gas chromatography-mass spectrometry analyses of hepatic lipids. RT-qPCR analysis of gene expression in the aorta revealed that the administration of the terpenoid fraction downregulated LOX-1, suggesting a reduction in atherosclerotic stimuli. In addition, a statistically significant reduction (p < 0.05) in PPARγ for the saponin fraction was observed in the liver. The expression of the ACAT-1 gene in the liver, responsible for the formation of cholesterol esters, increased significantly in the group receiving the terpenoid fraction compared to the control, which was also confirmed by the analysis of individual blood biochemical parameters. The opposite effect was observed for saponins. Taking the above into account, it is shown for the first time that Ilex aquifolium can be a source of compounds that positively influence lipid metabolism.Entities:
Keywords: Zucker rats; lipid metabolism; saponins; terpenoids
Mesh:
Substances:
Year: 2022 PMID: 35684317 PMCID: PMC9182309 DOI: 10.3390/molecules27113376
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Aroma profile of Argentine I. paraguariensis and European I. aquifolium and I. meserveae.
| Compound | RI Exp. 1 | RI Lit. 2 |
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|
| Alaska | Ferox Argentea | Rubricaulis Aurea | Blue Angel | Blue Boy | Golden Girl | ||||
| Concentration (µg g−1) d.w | |||||||||
| Hexanal | 802 | 800 | 13.80 3a | - 4 | - | - | 1.52 c | 1.18 c | 2.45 b |
| 2-Methyl-2-pentenal | 838 | 837 | 11.77 | - | - | - | - | - | - |
| ( | 860 | 854 | 1.77 a | 0.68 a | - | - | 12.28 b | 20.97 d | 14.61 c |
| 3-Hexen-1-ol | 864 | 856 | - | 0.14 a | - | - | 11.85 d | 8.52 c | 6.34 b |
| α-Pinene | 938 | 937 | 0.23 a | 1.98 d | 2.77 e | 3.94 f | 1.32 c | 0.62 b | 0.51 ab |
| 6-Methyl-5-heptene-2-one | 960 | 956 | 25.73 | - | - | - | - | - | - |
| α-Phellandrene | 989 | 986 | - | 4.71 d | 3.68 c | 5.44 d | 2.39 b | 1.05 a | 1.16 a |
| ( | 1012 | 1012 | 14.83 | - | - | - | - | - | - |
| p-Cymene | 1027 | 1025 | 2.65 a | 74.40 f | 58.21 e | 82.62 g | 32.75 d | 20.20 b | 22.51 c |
| ( | 1074 | 1068 | 22.82 | - | - | - | - | - | - |
| Total | 93.60 | 81.91 | 64.66 | 92.00 | 62.11 | 52.54 | 47.58 | ||
1 Experimental retention indices calculated against n-alkanes. 2 Retention indices according to the NIST20 database. 3 Values are mean; values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test). 4 not detected.
Profile of triterpenoids in I. paraguariensis and various varieties of I. aquifolium and I. meserveae.
| Compound, TMS 1 | RI Exp. 2 | RI Lit. 3 |
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|
| Alaska | Ferox Argentea | Rubricaulis Aurea | Blue Angel | Blue Boy | Golden Girl | ||||
| Concentration (mg g−1) d.w | |||||||||
| β-Amyrin | 3369 | 3353 | 1.44 4a | 1.21 b | 0.90 d | 0.49 e | 1.87 c | 1.95 c | 1.43 a |
| α-Amyrin | 3412 | 3406 | 4.28 a | 3.22 b | 1.87 d | 0.36 e | 3.07 b | 1.75 d | 2.18 c |
| Lupeol | 3429 | 3435 | 1.05 a | 2.18 e | 1.39 b | 0.42 c | 1.86 d | 1.35 b | 2.53 f |
| Uvaol | 3531 | 3540 | 2.21 a | 2.42 a | 1.03 c | 0.37 d | 0.99 c | 1.70 b | 2.48 a |
| Betulinic acid | 3579 | 3588 | 1.42 a | 0.98 b | 0.50 d | 0.76 c | 0.19 e | 0.42 d | 0.59 cd |
| Oleanolic acid | 3593 | 3591 | 2.03 a | 4.89 e | 3.45 c | 2.87 b | 4.08 d | 6.52 f | 4.31 d |
| Ursolic acid | 3664 | 3657 | 1.23 a | 15.55 f | 10.22 c | 7.29 b | 14.44 e | 16.11 g | 13.51 d |
| Total | 13.66 | 30.45 | 19.36 | 12.56 | 26.50 | 29.80 | 27.03 | ||
1 All compounds are TMS derivatives. 2 Experimental retention indices calculated against n-alkanes. 3 Retention indices according to the NIST20 database. 4 Values are mean; values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test).
Fatty acid profile and nutritional indices in leaves of I. paraguariensis and various varieties of I. aquifolium and I. meserveae.
| Fatty Acid 1 | RI Exp. 2 | RI Lit. 3 |
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Alaska | Ferox Argentea | Rubricaulis Aurea | Blue Angel | Blue Boy | Golden Girl | |||||
| Concentration (mg g−1) d.w | ||||||||||
| Palmitic acid | C16:0 | 1599 | 1600 | 18.08 4a | 12.05 d | 15.03 b | 12.66 d | 14.03 bc | 13.04 cd | 12.51 d |
| Stearic acid | C18:0 | 1801 | 1800 | 6.39 a | 2.37 c | 4.17 b | 2.50 c | 4.12 b | 2.56 c | 2.60 c |
| Oleic acid | C18:1ω9 | 1817 | 1819 | 9.03 a | 3.60 e | 4.39 c | 3.92 d | 7.61 b | 3.41 e | 3.37 e |
| Linoleic acid | C18:2ω6 | 1867 | 1874 | 4.23 a | 8.40 d | 5.84 b | 8.72 e | 5.63 b | 8.21 c | 10.08 f |
| α-Linolenic acid | C18:3ω3 | 1933 | 1928 | 5.92 a | 21.31 d | 9.72 b | 19.28 c | 9.09 b | 19.61 c | 22.16 d |
| Arachidonic acid | C20:4ω3 | 2118 | 2115 | 2.71 a | 0.71 c | 9.11 e | 0.54 cd | 1.84 b | 0.40 d | 0.58 cd |
| Docosahexaenoic acid | C22:6ω3 | 2419 | 2416 | 1.67 a | 0.53 cd | 1.73 a | 0.66 c | 0.93 b | 0.45 d | 0.66 c |
| ∑SFA | 48.27 a | 30.38 g | 43.26 b | 32.85 e | 40.78 c | 33.26 d | 30.82 f | |||
| ∑UFA | 51.74 a | 69.64 g | 56.74 b | 67.15 e | 59.24 c | 66.75 d | 69.21 f | |||
| ∑MUFA | 25.31 a | 11.15 e | 29.78 c | 11.91 d | 23.41 b | 10.38 f | 9.45 g | |||
| ∑PUFAω6 | 12.28 a | 17.37 e | 14.24 b | 17.61 f | 14.87 c | 17.22 d | 18.64 g | |||
| ∑PUFAω3 | 14.16 a | 41.12 f | 12.72 b | 37.63 d | 20.96 c | 39.15 e | 41.12 f | |||
| IA 5 | 0.77 a | 0.42 c | 0.69 a | 0.43 c | 0.62 ab | 0.44 bc | 0.50 bc | |||
| IT 6 | 0.69 a | 0.20 c | 0.62 a | 0.23 c | 0.46 b | 0.22 c | 0.22 c | |||
| PUFA/SFA 7 | 0.57 a | 1.96 d | 0.63 a | 1.70 c | 0.91 b | 1.74 c | 1.90 d | |||
| h/H 8 | 1.24 a | 2.73 d | 1.17 a | 2.41 c | 1.72 b | 2.39 c | 2.66 d | |||
| UI 9 | 110.07 a | 174.73 d | 142.87 c | 169.17 d | 126.82 b | 168.16 d | 175.87 d | |||
1 All compounds are expressed as GC-MS percentage of methyl esters; 2 experimental retention indices calculated against saturated fatty acids; 3 retention indices according to the Lipids Library 1.0; 4 values are mean; values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test); 5 IA, Index of Atherogenicity; 6 IT, Index of Thrombogenicity; 7 PUFA/SFA, polyunsaturated fatty acid/saturated fatty acid; 8 h/H, Hypocholesterolemic/Hypercholesterolemic Index; 9 UI, Unsaturation Index.
Body weight, feed intake and liver weight.
| Group | ||||
|---|---|---|---|---|
| CON | SAP | TERP | ||
| Initial body weight (g) | 298.86 ± 65.89 1 | 299.29 ± 15.24 | 293.71 ± 14.02 | 0.282 |
| Final body weight (g) | 521.00 ± 44.39 | 512 ± 51.91 | 528.14 ± 35.18 | 0.346 |
| Feed intake (g/week) | 123 ± 8.98 | 118 ± 6.62 | 132 ± 9.32 | 0.682 |
| Liver weight (g) | 23.10 ± 2.01 | 22.73 ± 4.19 | 24.06 ± 1.77 | 0.534 |
1 Values are mean ± SD.
Figure 1Weight changes after using saponins and terpenoids over a period of 8 weeks.
Hematological parameters in Zucker rats after treatment with saponin and terpenoid fractions.
| Group | ||||
|---|---|---|---|---|
| CON 1 | SAP 2 | TERP 3 | ||
| WBC 5 G/L | 6.16 ± 1.02 4a | 8.66 ± 1.10 | 9.17 ± 2.19 b | 0.046 |
| RBC 6 T/L | 6.73 ± 1.04 a | 7.38 ± 0.75 | 7.47 ± 1.24 b | 0.006 |
| HGB 7 mmol/L | 7.37 ± 0.95 | 7.81 ± 0.76 | 7.80 ± 1.30 | 0.100 |
| HCT 8 L/L | 0.32 ± 0.05 a | 0.35 ± 0.03 | 0.35 ± 0.05 b | 0.010 |
| MCV 9 fL | 47.29 ± 0.76 | 46.71 ± 1.25 | 46.71 ± 1.38 | 0.296 |
| MCH 10 fmoL | 1.10 ± 0.06 | 1.06 ± 0.03 | 1.04 ± 0.03 | 0.402 |
| MCHC 11 mmol/L | 23.31 ± 1.45 a | 22.54 ± 0.64 a | 22.36 ± 0.69 b | <0.001 |
| PLT 12 G/L | 431.00 ± 242.83 | 575.14 ± 253.74 | 674.00 ± 180.63 | 0.003 |
1 Control group; 2 rats fed a standard diet with the addition of saponin fraction; 3 rats fed a standard diet with the addition of terpenoid fraction; 4 values are mean ± SD; different letters within a row indicate significant differences between groups (p < 0.05; ANOVA followed by the post hoc test); 5 WBC, white blood cells; 6 RBC, red blood cells; 7 HGB, hemoglobin; 8 HCT, hematocrit; 9 MCV, mean corpuscular volume; 10 MCH, mean corpuscular hemoglobin; 11 MCHC, mean corpuscular hemoglobin concentration; 12 PLT, platelets.
Mean values of lipid and biochemical parameters and activity of AST in blood Zucker rats.
| Group | ||||
|---|---|---|---|---|
| CON 1 | SAP 2 | TERP 3 | ||
| Glucose mmol/L | 6.54 ± 0.62 4 | 5.39 ± 1.59 4 | 5.56 ± 1.85 4 | 0.303 |
| Insulin pg/mL | 4015.80 ± 1714.38 | 3066.41 ± 1458.38 | 3078.84 ± 1134.45 | 0.394 |
| Chol. 5 mmol/L | 4.92 ± 0.34 | 4.63 ± 1.19 | 5.14 ± 0.93 | 0.574 |
| HDL 6 mmol/L | 2.11 ± 0.23 | 1.93 ± 0.52 | 2.13 ± 0.22 | 0.524 |
| LDL 7 mmol/L | 2.80 ± 0.29 | 2.71 ± 0.35 | 3.01 ± 0.27 | 0.426 |
| TG 8 mmol/L | 4.13 ± 0.82 a | 4.87 ± 1.94 | 6.09 ± 1.44 a | 0.057 |
| NEFA 9 mmol/L | 1.87 ± 0.42 | 1.63 ± 0.2 a | 2.15 ± 0.47 b | 0.062 |
| AST 10 U/L | 186.31 ± 74.71 | 152.29 ± 21.23 | 150.30 ± 27.16 | 0.304 |
| TP 11 g/L | 75.21 ± 4.61 | 73.99 ± 4.07 | 76.06 ± 5.26 | 0.711 |
| Alb. 12 g/L | 32.81 ± 2.62 | 34.70 ± 3.53 | 34.06 ± 1.34 | 0.419 |
1 Control group; 2 rats fed a standard diet with the addition of saponin fraction; 3 rats fed a standard diet with the addition of terpenoid fraction; 4 values are mean ± SD; different letters within a row indicate significant differences between groups (p < 0.05; ANOVA followed by the post hoc test); 5 Chol., cholesterol; 6 HDL, high-density lipoprotein; 7 LDL, low-density lipoprotein; 8 TG, triglycerides; 9 NEFA, non-esterified fatty acids; 10 AST, aspartate aminotransferase; 11 TP, total protein; 12 Alb., albumin.
Effects of saponin and terpenoids on antioxidant and immunological parameters in Zucker rats.
| Group | ||||
|---|---|---|---|---|
| CON 1 | SAP 2 | TERP 3 | ||
| TAS 5 mmol/L | 1.43 ± 0.29 4a | 1.82 ± 0.07 4b | 1.79 ± 0.04 4c | 0.001 |
| GR 6 U/L | 602.29 ± 373.21 a | 319.14 ± 120.27 b | 423.67 ± 211.92 | 0.030 |
| IL-6 7 pg/mL | 1.22 ± 0.12 | 1.22 ± 0.26 | 1.21 ± 0.12 | 0.989 |
| IL-10 8 pg/mL | 1.41 ± 1.84 | 1.95 ± 1.49 | 2.89 ± 1.40 | 0.237 |
| MCP-1 9 ng/mL | 0.51 ± 0.27 | 0.72 ± 0.35 | 0.76 ± 0.16 | 0.214 |
| ROS 10 U/mL | 73.70 ± 3.14 a | 65.76 ± 4.77 b | 73.34 ± 6.48 b | 0.012 |
| NO 11 µmol/L | 0.19 ± 0.04 | 0.13 ± 0.09 | 0.17 ± 0.06 | 0.238 |
1 Control group; 2 rats fed a standard diet with the addition of saponin fraction; 3 rats fed a standard diet with the addition of terpenoid fraction; 4 values are mean ± SD; different letters within a row indicate significant differences between groups (p < 0.05; ANOVA followed by the post hoc test); 5 TAS, total antioxidant status; 6 GR, glutathione reductase; 7 IL-6, interleukin-6; 8 IL-10, interleukin-10; 9 MCP-1, blood monocyte chemotactic protein-1; 10 ROS, reactive oxygen species; 11 NO, nitric oxide.
Fatty acid profile in Zucker rat liver.
| Fatty Acid 1 | RI Exp. 2 | RI Lit. 3 | Group | |||
|---|---|---|---|---|---|---|
| CON 4 | SAP 5 | TERP 6 | ||||
| % of Total Hepatic Triacylglicerols | ||||||
| Myristic acid | C14:0 | 1399 | 1400 | 2.36 7a | 2.56 b | 2.13 c |
| Palmitic acid | C16:0 | 1598 | 1600 | 23.92 a | 25.54 b | 23.33 c |
| Palmitoleic acid | C16:1ω7 | 1636 | 1632 | 9.56 a | 10.77 c | 9.02 b |
| Stearic acid | C18:0 | 1800 | 1800 | 11.52 a | 12.05 c | 11.64 b |
| Elaidic acid | C18:1ω9t | 1821 | 1818 | 17.64 a | 21.44 c | 15.61 b |
| Oleic acid | C18:1ω9 | 1818 | 1819 | 4.34 a | 4.62 c | 4.21 b |
| Vaccenic acid | C18:1ω7 | 1829 | 1823 | 0.18 ab | 0.23 b | 0.15 a |
| Linoleic acid | C18:2ω6 | 1866 | 1874 | 8.34 a | 6.75 b | 8.32 a |
| γ-Linolenic acid | C18:3ω6 | 1899 | 1896 | 0.27 a | 0.20 b | 0.21 b |
| α-Linolenic acid | C18:3ω3 | 1931 | 1928 | 1.79 a | 1.57 b | 1.40 c |
| Gondoic acid | C20:1ω9 | 2018 | 2022 | 0.17 a | 0.12 a | 0.06 b |
| Dihomo-γ-linolenic acid | C20:3ω6 | 2091 | 2096 | 1.76 a | 1.14 c | 1.68 b |
| Arachidonic acid | C20:4ω6 | 2117 | 2115 | 9.01 a | 6.61 c | 11.71 b |
| Eicosapentaenoic acid | C20:5ω3 | 2179 | 2181 | 1.22 a | 0.78 b | 1.23 a |
| Docosapentaenoic acid | C22:5ω3 | 2359 | 2362 | 1.43 a | 1.06 c | 1.31 b |
| Docosahexaenoic acid | C22:6ω3 | 2418 | 2416 | 6.44 a | 4.42 c | 8.03 b |
| FA content of the liver (µg/mg) | 215 a | 208 a | 172 b | |||
| ∑SFA 8 | 37.81 a | 40.17 c | 37.07 b | |||
| ∑MUFA 9 | 31.96 a | 37.26 c | 29.05 b | |||
| ∑PUFA 10 | 30.22 a | 22.56 c | 33.88 b | |||
| ∑PUFAω6 | 19.37 a | 14.71 c | 21.91 b | |||
| ∑PUFAω3 | 10.85 a | 7.85 c | 11.97 b | |||
1 All compounds are expressed as GC-MS percentage of methyl esters; 2 experimental retention indices calculated against saturated fatty acids; 3 retention indices according to the Lipids Library 1.0. 4 control group; 5 rats fed a standard diet with the addition of saponin fraction; 6 rats fed a standard diet with the addition of terpenoid fraction; 7 values are mean; values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test); 8 SFA, saturated fatty acid; 9 MUFA, monounsaturated fatty acids; 10 PUFA, polyunsaturated fatty acids.
Figure 2Expression of genes after treatment of saponin and terpenoid fraction in Zucker rat aorta. CON, control group; SAP, rats fed a standard diet with the addition of saponin fraction; TERP, rats fed a standard diet with the addition of terpenoid fraction. Values were normalized against Gapdh expression and presented as a fold-change in relation to gene expression in a control group. Specific comparisons: * p < 0.05 vs. CON; # p < 0.05 vs. SAP (ANOVA followed by the post hoc test). TNFα, tumor necrosis factor alpha; PPARα, peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; LOX1, lectin-type oxidized LDL receptor; MMP1, matrix metalloproteinase-1; NOS3, nitric oxide synthase 3; NOX1, NADPH oxidase 1; ACAT1, acetyl-CoA acetyltransferase 1.
Figure 3Expression of genes after treatment of saponin and terpenoid fraction in Zucker rat liver. CON, control group; SAP, rats fed a standard diet with the addition of saponin fraction; TERP, rats fed a standard diet with the addition of terpenoid fraction. Values were normalized against Gapdh expression and presented as a fold-change in relation to gene expression in a control group. Specific comparisons: * p < 0.05 vs. CON; # p < 0.05 vs. SAP (ANOVA followed by the post hoc test). HMGR, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase; MMP9, matrix metallopeptidase 9; PPARalpha, peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; ACAT1, acetyl-CoA acetyltransferase 1; ACC1, acetyl-CoA carboxylase 1; ACC2, acetyl-CoA carboxylase 2; LXR1, liver X receptor; SREB1c, sterol regulatory element-binding protein 1.
Figure 4Representative pictures of rat liver stained with hematoxylin and eosin ((A–C) upper panel) and PMP70 immunohistochemical staining for the 70 kDa peroxisomal membrane protein marker PMP70 ((D–F) yellow signals in lower panel; solid arrowhead = positive signals detecting the presence of the peroxisomes in controls and experimental groups). Note the degree of steatosis—different amounts and sizes of the fat droplets in the hepatocytes (solid arrows = hepatocytes; open arrows = central vein) in pictures stained with hematoxylin and eosin. Mag. 200×. Scale bar 100 µm (A–F).
Primer sequences. MMP1, matrix metalloproteinase-1; HMGR, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase; TNFα, tumor necrosis factor alpha; PPARα, peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; ACAT1, acetyl-CoA acetyltransferase 1; ACC1, acetyl-CoA carboxylase 1; ACC2, acetyl-CoA carboxylase 2; LXR1, liver X receptor; SREB1c, sterol regulatory element-binding protein 1; LOX1, lectin-type oxidized LDL receptor; NOS3, nitric oxide synthase 3; NOX1, NADPH oxidase 1.
| Gene Symbol | Forward Primer | Reverse Primer |
|---|---|---|
|
| 5′-CCACTAACATTCGAAAGGGTTT-3′ | 5′-GGTCCATCAAATGGGTTATTG-3′ |
|
| 5′-CTTGACGCTCTGGTGGAATG-3′ | 5′-GTTGGCAAGCACGGACATA-3′ |
|
| 5′-GCCCAGACCCTCACACTC-3′ | 5′-CCACTCCAGCTGCTCCTCT-3′ |
|
| 5′-TCACACAATGCAATCCGTTT-3′ | 5′-GGCCTTGACCTTGTTCATGT-3′ |
|
| 5′-GAGATCCTCCTGTTGACCCAG-3′ | 5′-CCACAGAGCTGATTCCGAAGT-3′ |
|
| 5′-CACAGAGCTGATTCCGAAGT-3′ | 5′-GAGCCATGCCTCTAGTACCT-3′ |
|
| 5′-TCTATTCGGGGTGACTTTC-3′ | 5′-CAATCAGTCTGTCCAGCCA-3′ |
|
| 5′-GGAACTCACGCAGTTGAGCAGG-3′ | 5′-CACATAAACCTCCAGGGACGCC-3′ |
|
| 5′-TGATGCTGAATTTGCTCTGC-3′ | 5′-GGCTCACCAGCTTCATTAGC-3′ |
|
| 5′-TGCCCTAAGGGTCAAAACCA-3′ | 5′-TGGCGGGCACTACTCAGGAA-3′ |
|
| 5′-TGATGCTGAATTTGCTCTGC-3′ | 5′-GGCTCACCAGCTTCATTAGC-3′ |
|
| 5′-GGGCTCCCTCCTTCCGGCTGC-3′ | 5′-GGATCCCTGGAAAAGGCG-3′ |
|
| 5′-TCTTGCTGGTTGACACTTGC-3′ | 5′-TATGGGAGTGGGAATCTTGG-3′ |